Ribbon-cutting celebrates new 65,000-sq.-ft. office and GMP warehouse in Horsham, PA.
Horsham, PA, September 22, 2021 – Myonex, a leading global clinical trial supply company, marked the opening of its new global headquarters and US operational facility with a ribbon-cutting ceremony on the company’s 14-acre campus.
“Let’s take a moment to remember the deeper reason why we’re here,” James Lovett, Chief Executive Officer at Myonex, said at the Sept. 21 event, noting that people die of diseases for which “the cures are not ready yet. For every patient, we are in a race against time to discover the right cure. At Myonex, our purpose—and this building’s purpose—is to help win this race more often.”
Acknowledging the critical importance of clinical trials, which take an average of six years and fall behind schedule 85 percent of the time, Lovett said, “At Myonex, our mission is to make clinical trial supply faster and less expensive” with services like packaging and distribution that can respond quickly to protocol changes; a new CTRx prescription service that can speed study start-up and eliminate wasted doses; end-to-end supply chain management for key equipment and supplies; and unique global drug sourcing capabilities that can potentially save millions of dollars.